Particle.news

Download on the App Store

Andy Cohen Says He Microdosed a GLP‑1 This Summer, Credits It for Weight Loss

He describes a doctor‑guided regimen addressing weight and cardiovascular risks, coupled with a call for wider insurance access.

Overview

  • He told listeners Tuesday on SiriusXM’s Radio Andy that he lost a “good chunk” of weight by microdosing a GLP‑1 during the summer.
  • People reported he characterized the change as about 25 pounds and that he is no longer on the microdose.
  • He said he and his doctor pursued the medication to address weight, arterial plaque and high blood pressure.
  • He did not name the specific drug and said it curbed cravings and reinforced discipline around diet, exercise and on‑set snacking.
  • He acknowledged privileged access through insurance, urged broader coverage, and advised consulting a medical professional; coverage noted GLP‑1s are used for diabetes and weight loss with other documented health benefits.